A service of StreetInsider.com
Welcome

Most Popular

AAPL 196.19
C 3.18
GOOG 536.44
BAC 14.47
RIMM 66.15

Recently Added

ATHX 2.88
MED 17.54
DANA 0.20
OWVI 0.00
IDC 29.18

Gaining Speed

MKSI 18.55
CTGI 0.14
HLXW 1.03
WHX 17.61
SWNM 0.00
0.68 +0.00 (0.00%) HEB

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:0.68 Change:+0.00 (0.00%) Prev Close:0.68 Open: 0.69 Days Range:0.67 – 0.69 52 Week Range: 0.26 - 4.54 Volume:1154152 P/E: N/A
EPS:-0.13

Member Comments

No member comments available for HEB


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 02/09/10

Recent Alert on 02/02/10 at 10:06am
Hemispherx (HEB) Receives Favorable Response from FDA Seattle Office Related to Ampligen Manufacturing Response

Hemispherx Biopharma, Inc. (Amex: HEB), announced that the Company, via its manufacturing subcontractor, received a favorable response from the FDA Seattle District Office related to the latest response to the Prior Approval Inspection submitted on... Read More

Recent Alert on 02/02/10 at 10:06am
Hemispherx (HEB) Receives Favorable Response from FDA Seattle Office Related to Ampligen Manufacturing Response
Recent Alert on 01/14/10 at 10:17am
Morning Movers 01/14: ETRM, LAB, TSTR, CROX, HEB Higher; ROSG, MRNA, IPII, MED Lower
Recent Alert on 01/14/10 at 9:51am
Hemispherx (HEB) Submits Reports of New Preclinical Data on Ampligen; Sees No Boost in Undesirable Cytokines
Recent Alert on 01/14/10 at 9:51am
Hemispherx (HEB) Submits Reports of New Preclinical Data on Ampligen; Sees No Boost in Undesirable Cytokines

View AllRecent Press Releases

Press Release on 02/08/10 at 8:45am
New Animal Model for Evaluating Antiviral Agents Against the SARS Virus Indicates Potential Effect of Ampligen(R), an Experimental Therapeutic

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 12/02/09 at 4:31pm
Equities Update: Flat Finish as Energies Weigh
Blog Posts on 11/13/09 at 5:01pm
Law Firms Going After Hemispherx
Blog Posts on 11/09/09 at 12:44pm
Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays
Blog Posts on 11/05/09 at 7:41am
Hemispherx Biopharma Could Become a Nice Rebound Story
Blog Posts on 10/29/09 at 6:51am
BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?